Taiko Pharmaceutical Co., Ltd. (JP:4574) has released an update.
Taiko Pharmaceutical Co., Ltd. has reported a significant turnaround in its financial performance, with net sales increasing by 14.9% to 2,860 million yen and operating profit rising to 482 million yen, recovering from a previous loss of 396 million yen. The company has also seen a substantial improvement in net assets, which have grown to 8,074 million yen alongside a strong capital adequacy ratio of 60.3%. These results reflect a robust recovery and growth trajectory for the company.
For further insights into JP:4574 stock, check out TipRanks’ Stock Analysis page.
